Determination of Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma and Other Biological Samples by High-Performance Liquid Chromatography
- 1 April 2002
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 303 (2) , 131-137
- https://doi.org/10.1006/abio.2001.5575
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patientsKidney International, 2001
- Does ADMA Cause Endothelial Dysfunction?Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Endogenous Nitric Oxide Synthase InhibitorCirculation, 1999
- Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 1999
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive DiseaseCirculation, 1997
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Modulation of platelet aggregation by an l-arginine-nitric oxide pathwayTrends in Pharmacological Sciences, 1991
- Nitric oxide: an endogenous modulator of leukocyte adhesion.Proceedings of the National Academy of Sciences, 1991
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988